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Case Presentation:
Erythrodermic Dermatomyositis  
Discussion:
Dermatomyositis (DM) is an autoimmune systemic disease that can involve 
the skin, musculoskeletal, gastrointestinal, cardiac and pulmonary systems. 
Pathognomonic cutaneous features include the heliotrope rash and Gottron’s 
papules.  Gottron’s papules are flat-topped erythematous papules and 
plaques typically found on joints of the hands and elbows. Poikiloderma, malar 
erythema, periungual telangiectasia, and photosensitivity are other common 
characteristic findings.  Dystrophic and ragged cuticles, known as Samitz sign, 
can be observed. Proximal muscle weakness may occur before, during, or after 
the presence of cutaneous findings. Systemic manifestations can present as 
arthralgia, arthritis, dyspnea, dysphagia, arrhythmia, and dysphonia.
Laboratory studies may yield an elevated creatine kinase, aldolase, aspartate 
aminotransferase or lactic dehydrogenase due to myositis.  A positive 
antinuclear antibody result is common but not diagnostic.  Several myositis-
specific antibodies have been identified but are not routinely used in diagnosis. 
They may, however, aid in the classification of DM subtypes for prognosis. Anti-
Mi-2 antibody is highly specific and is associated with acute-onset classic DM 
with a relatively good prognosis.  Anti–Jo-1 antibodies are more common in 
patients with polymyositis and can be associated with interstitial lung disease, 
Raynaud phenomenon, and arthritis. Juvenile onset DM has the best prognosis 
for survival, while paraneoplastic DM has the worst prognosis.  A malignancy 
work up should be performed in all patients with adult onset DM. Multiple 
associated malignancies have been reported, including ovarian and breast 
cancer in women and lung cancer in men.
Erythroderma is an uncommon presentation of DM and can be associated 
with an underlying malignancy. Documented cases include erythrodermic DM 
associated with gastric cancer, liver cancer, and adenocarcinoma. Our patient 
with erythrodermic DM has had a negative malignancy work up to date. After 
3 months on mycophenolate mofetil, hydroxychloroquine, prednisone, and 
topical clobetasol, he has cleared significantly. He occasionally experiences 
musculoskeletal pain but no longer experiences weakness. 
Laboratory studies, malignancy work up, referral to appropriate specialists, 
and treatment to control cutaneous and muscle disease are important in 
the management of DM. Treatment options include topical and systemic 
corticosteroids, antimalarial agents, and immunomodulators. Systemic 
corticosteroids has been first line in the treatment of muscle disease.  
Methotrexate, mycophenolate mofetil, or azathioprine can be used as steroid-
sparing agents. Sun avoidance and sun protection are important to avoid 
further exacerbations of skin disease.  
Patient: 50 year-old Caucasian male. 
History of Present Illness: This patient presented with 
a 15-week history of a rash over his entire body.  The rash is associated 
with pruritus and edema. Prior treatments include prednisone, hydroxyzine, 
cetirizine, famotidine, and triamcinolone with some improvement. He 
reports odynophagia, unintentional 10 pound weight loss within the last 
3-4 months, and occasional difficulty lifting both arms. He denied nausea, 
vomiting, headaches, changes in urinary patterns, and back pain.
Medical History/Surgical History: Hypothyroidism, 
sleep apnea, inguinal hernia repair 
Family History: Hypertension, amyotrophic lateral sclerosis
Medications: Levothyroxine
Previous Treatment: Prednisone, hydroxyzine, cetirizine, 
famotidine, triamcinolone  0.1% ointment  
Current Treatment: Prednisone, hydroxychloroquine, 
mycophenolate mofetil, clobetasol 0.05% ointment
Physical Examination: Generalized erythematous patches 
on the extensor surfaces of the upper extremities and most of the trunk.  
There is confluent erythema and edema of the lower extremities with 
sparing of the popliteal fossa and lateral feet. Scaly erythematous papules 
and patches on the dorsal hands with distinct flat-topped papules over the 
PIP and DIP joints and dorsal toes. Erythema and edema on face, ears, and 
the upper eyelids. There is hyperkeratosis and prominent telangiectatic 
vessels in the proximal nail folds with ragged cuticles. There is a palpable 
1cm lymph node in the right axilla. Genitals are spared.   No muscle 
weakness on initial exam.
Laboratory Data: (9/19/2014) Creatinine kinase 1148 (<351), 
AST 104 (<41), ALT 57 (<56), Aldolase 16.3 (1.5-8.1), ANA negative; 
(7/17/14) UA, urine porphyrins, serum complement, ACE, ESR, CRP, HLB-
27 and creatine kinase WNL. Anti-thyroglobulin Ab 42 (0-40), anti-thyroid 
peroxidase Ab 337(0-34); (05/24/14) CMP, uric acid, RF, ESR, TSH and CBC 
WNL except lymphocyte count 0.79(1.2-4.8) 
Studies: MRI brain, CT scan of head/neck, chest, and abdomen were 
negative for underlying malignancy (10/10/14). Colonoscopy, endoscopy 
(10/2/14), PFT (10/14/14), and left inguinal node biopsy (9/30/14) were 
negative for malignancy. 
Biopsy: CBL Path (D14NY1-0234678, 08/15/14) Left 3rd finger 
dorsal DIP, right knee: Interface dermatitis. “Mild acanthosis and patchy 
parakeratoisis with sparse perivascular infiltrate”. Left arm- Punch DIF: 
Granular deposition of IgG in epidermis and C3 in BMZ. 
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Figure 1: Heliotrope Rash.
Figure 2: Erythema of the hands with Gottron’s 
papules along the DIP joints and ragged cuticles.
Figure 3: Erythroderma of the neck and trunk.
Figure 4a: Magnification 10x- Mild acanthosis and 




 Fig. 4a (10x)
 Fig. 4b (20x)
Figure 4b: Magnification 20x.
Figure 1: Heliotrope rash.
